<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397495838</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164520.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199507  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1016/S1010-7940(05)80167-8</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1016/S1010-7940(05)80167-8</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Results of surgical treatment of stage IIIA non-small cell lung cancer</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">From 1975 to 1993, 665 patients with non-small cell lung carcinoma(NSCLC) were studied in our Unit. Of the 55 stage IIIA patients submittedto resection, 50 were followed-up in order to evaluate the effectiveness ofsurgery and to identify which variables had a prognostic impact onsurvival. The expectancy of survival at 3,5 and 10 years was 31.7, 19.5 and13.7%, respectively. When the analysis was limited to N2 patients, 3,5- and10-year survival rates were 20.9, 14 and 7%, respectively. Regarding the&quot;TN&quot; factor, the T3N0 subset presented the highest expected survival (24.8and 18.6% at 5 and 10 years). With regard to the &quot;T3&quot; factor and type ofsurgery, peripheral tumors submitted to en bloc resection of the chest wallshowed the best 5-year survival rate (42.9%), whereas extrapleuralresections--even for tumors confined to the parietal pleura--showed a5-year survival rate of 14.3%. A slightly higher risk of death was observedin tumors originating in the superior sulcus (SST). No patients withmediastinal pleura and pericardium involvement survived more than 34months. With univariate analysis, &quot;N2&quot; was the variable most significantlyassociated with a negative prognosis when related to T3 (T3N2 vs T3N0 0.025&lt; P &lt; 0.05) or non-epidermoid tumor (no survivors at 3 years; N2epidermoid vs N2 non-epidermoid tumor P &lt; 0.05). Applying multivariateanalysis, epidermoid cell type, even if exclusively for N2 tumors, was anindependent prognostic factor, showing a favorable impact on survivalexpectancy (27.8% at 90 months).</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V.</subfield>
   <subfield code="g">9/7(1995-07), 352-359</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:7&lt;352</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80167-8</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">abstract</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80167-8</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V</subfield>
   <subfield code="g">9/7(1995-07), 352-359</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:7&lt;352</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="986" ind1=" " ind2=" ">
   <subfield code="a">SWISSBIB</subfield>
   <subfield code="b">397242336</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
